Client Gossamer Bio Promotes Richard Aranda to CMO

We are excited to share that our client, Gossamer Bio, a clinical stage company with current programs in oncology, immunology, and inflammation, has promoted Richard Aranda, M.D. to Chief Medical Officer. Dr. Aranda joined Gossamer in 2018 at the SVP and Head of Clinical Development, leading Gossamer into the clinic and building out the development team. Currently, Dr. Aranda and the Gossamer team have paired with Westwood & Wilshire to fill the Executive Director of Clinical Development in Hematology and Oncology role.

Faheem Hasnain, Chairman, co-founder and CEO of the company told Business Wire, “Dr. Richard Aranda’s clinical development expertise has been vital to Gossamer since inception. Dr. Aranda is an experienced drug developer and clinician, and under his continued strong leadership, I am confident that Gossamer is best positioned for success.”

As CMO, Dr. Aranda will continue to have oversight over Clinical Pharmacology, Translational Medicine, Pharmacovigilance, as well as the rest of Clincal Development at Gossamer.

Congratulations from Westwood & Wilshire to Dr. Aranda and the whole Gossamer team on their continued success.